190 filings
Page 5 of 10
8-K
tx2gm8w4xyif
28 Mar 19
Entry into a Material Definitive Agreement
8:45am
8-K
kzt5qrb
12 Mar 19
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
4:30pm
8-K
1ibjmvsphgxgzycx7xc
11 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
5i4g4mbt 7sv26xsmpb
1 Mar 19
Entry into a Material Definitive Agreement
12:00am
8-K
9ik 9g993r7ck6lpihmo
11 Oct 18
Departure of Directors or Certain Officers
4:30pm
8-K
bmz6ja a9co
28 Sep 18
NovaBay Pharmaceuticals Names Jack McGovern Interim CEO
4:30pm
8-K
jo3lf2x
4 Jun 18
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
r6qx75sa
26 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
wti0mtyikyz5j8dai3
23 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
v3xv46pqyj6msxyqtriu
12 Feb 18
NovaBay Pharmaceuticals Completes $6.0 Million Private Placement
12:00am
8-K
l70pneat 07
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
cdk8ki1vkw5dp8adxsan
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
2phfv1k4ge4x
22 Dec 17
NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement
12:00am
8-K
z3xxnw
20 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
xysynw aoslkm5
12 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
5ur04
28 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
js4 ofwmaxioje
21 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
kdt3gfx 8omgnl
20 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
9lia0hvriymvcyh
10 Jul 17
NovaBayPharmaceuticals Announces CFO Transition
12:00am
8-K
n5fp19ih8tqt6j1cpgdf
6 Jun 17
Departure of Directors or Certain Officers
12:00am